01 1Aurisco Pharmaceutical
01 1FLUTICASONE FUROATE
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2021-03-03
Pay. Date : 2021-01-22
DMF Number : 33636
Submission : 2019-03-21
Status : Active
Type : II
20
Aurisco Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their notable products is FLUTICASONE FUROATE, with a corresponding US DMF Number 33636.
Remarkably, this DMF maintains an Active status since its submission on March 21, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 03, 2021, and payment made on January 22, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II
